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I,

INTRODUCTION

The discoveries made at the end of the 19th centruy
concerning the importance of infectious micro-organisms in
human disease provoked great interest
response of the body to infection*

in the physiologic

It was at this time that

the biology of inflammation was first carefully studied and
accurately described.

In 1882 Julius Cohnheim presented his lect¬

ures describing the microscopic vascular events which occur in
acutely inflammed tissues as he observed them in the mesentery
and tongue of the frog; from his descriptions -- of vascular dila¬
tation, transudation of fluid, margination of white cells against
vessel walls and migration of the white cells into the extravascular spaces -- have sprung several channels of basic re¬
search on mechanisms of acute inflammation,^
Soon after Cohnheim*s reports, Elie MetchniRoff
clarified the role of the inflammatory process and particularly
of polymorphonuclear leukocytes (neutrophils)
tection against inflammatory disease,

in natural pro¬

"The diapedesis of the white

corpuscles, their migration through the vessel wall into the
cavities and tissues,

is one of the principal means of defence

possessed by an animal. As soon as the infective agents have
penetrated into the body, a whole army of white corpuscles pro¬
ceed towards the menaced spot, there entering into a struggle
with the micro-organisms."

2

Metchnikoff represented the tissue damage of acute
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inf lamination largely through military metaphors -- the necessary
result of battles between the invading microbe and host. How¬
ever, his studies recognized the importance of digestive "fer¬
ments" and "cytases" contained in neutrophils for the function of
these cells,

"The leukocytes, having arrived at the spot where

the intruders are found, seize them after the manner of Amoebae
and within their bodies subject them to intracellular digestion.
This digestion takes place

in the vacuoles in which usually is

a weakly acid fluid which contains digestive ferments,"

3

Since the turn of the century, the "ferments" and
the process of phagocytosis have been studied with more refine¬
ment by techniques of modern cell biology and enzymology.

In

particular, the digestive enzymes contained in neutrophils have
been studied as they act as mediators of the tissue damage in
acute inflammation. The release of these digestive enzymes during
phagocytosis is the subject of several studies with human neu¬
trophils _in vitro to be presented in this report.
It had been proposed at the time of Metchnikoff’s
studies that oneof the functions of inflammatory leukocytes might
be to deliver bactericidal substances to the sites of infection,
for it was known that white cell extracts lent bactericidal
properties to normal serum, Metchnikoff’s observations, however,
led him to believe that the neutrophils1 bactericidal "ferments"
served essentially the mechanisms of phagocytosis and intracell¬
ular digestion of foreign particles or microbes and were released

into the tissues only with the disruption of these cells, "The
cytases must be grouped with the soluble ferments which are not
thrown off by the phagocytes as long as these remain intact.

Im¬

mediately these cells are injured, however, they allow a part of
their cytases to escape,"
Interest in the character and function of the pro¬
teolytic and other hydrolytic

enzymes contained in neutrophils

has focused not only on the role

of these enzymes in the

protection against infecting micro-organisms but also on their
role in processes that are themselves harmful to the body. As
soon as the protective function of inflammation was recognized,
it was also recognized that the inflammatory process could be
misdirected and could itself produce disease.
Experimentation with models of inflammation wherein
the inflammatory response rather than the inflammatory stimulus
is harmful has accompanied the increasing study and recognition
of diseases associated with diffuse or localized inflammation
which offers no apparent protective function. Among these
diseases are the so-called "immune complex" vasculitides, post¬
streptococcal glomerulonephritis, and acute gouty arthritis.
The Arthus Phenomenon,

in particular, first described

in 1903, has been an experimental archetype of misdirected
inf lamination.J Arthus observed that once an experimental animal
is immunized against a foreign protein, this protein injected
into the skin of the animal provokes an inflammatory response
at the site of injection resulting in tissue necrosis.

It was

demonstrated subsequently that this tissue damage is a direct
consequence, not of the antigen-antibody complexes which form in
the skin of the experimental animal, but of the classic events of
inflammation which are provoked by these protein complexes,^^
Neutrophils are attracted to the sites where deposition of an¬
tigen-antibody complexes occurs, and there they phagocytize
these complexes,

6 7 8

1

'

*

The tissue damage resulting from the exper¬

imental inflammation in the Arthus Phenomenon depends upon the
presence of neutrophils in the tissues. Tissue damage does not
occur when neutrophils are prevented from accumulating either
by rendering the animal leukopenic

°

10 11
’

reactions in the blood complement system,

or by inhibiting
initiated by the form¬

ation of antigen-antibody complexes, which attract neutrophils
12 13
to the experimental site, *
A model of misdirected inflammation which has been
explored similarly is one in which urate crystals are infused
into the joints of humans or animals; the crystals provoke an
acute inflammation in which the inflammatory exudate consists
primarily of neutrophils, which may be observed to phagocytize the
crystals.

- -

Infusion of urate crystals into leukopenic ani¬

mals results neither in inflammation nor in tissue injury,1
Investigations concerning the mechanisms of tissue
injury produced by phagocytizing neutrophils in these experi¬
mental models have commanded particular interest in recent
years, for an understanding of these mechanisms promises the
eventual control of various inflammatory diseases. One of the

5-
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first proposals which related tissue injury to the
accumulation of neutrophils in the inflammatory response was
that the concentrations of lactic acid produced by accumulated
neutrophils are toxic to tissues,^

*1

It has been well demon¬

strated that an increased production of lactic acid by neutrophils
occurs during phagocytosis and under anaerobic conditions? also,
direct measurements of pH in inflammatory, transudative fluids
in which neutrophil accumulation occurs have shown a fall in
19
pH over time as a function of the number of neutrophils present.'
More recently, however, attention has turned to the various di¬
gestive enzymes contained in neutrophils as important med¬
iators of tissue injury in acute inflammation.
By the mid-l9509s it was known that neutrophils con¬
tain enzymes capable of degrading polymers of amino-acids,
carbohydrates, lipids, and phosphorylated or sulphated compounds
and are thus well equipped for the digestion of a variety of
tissue substrates,

22 23
’
A significant advance in understanding

the mobilization of these enzymes was made when it was recognized
that the enzymes are stored in intracellular organelles long
characterized morphologically as "granules," In 1955 De Duve
described in rat liver cells a class of cytoplasmic organelles,
"lysosomes," which contain several distinct acid hydrolytic
enzymes? these enzymes were found to exhibit activity only
when released from the organelles into a soluble phase."

*36

It was recognized that enzymes contained in neutrophil granules

6-
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behave after the manner of lysosomal enzymes in that they exhibit activity only when the intact granules are disrupted.

27

Morphological studies of phagocytizing neutrophils, with both
light and electron microscopy, have elucidated the mechanism
by which their "lysosomal" enzymes are mobilized for the digestion
of phagocytized particles? the membrane shell of the granules
fuses with the membrane enclosing the phagocytic vacuole con¬
taining an ingested particle, and therby the granules release
their enzymes into the vacuoles.

In this way the neutrophil is

"degranulated" during phagocytosis,- ”32
Various enzymes isolated from neut»phil granules have
been shown to be active in degrading tissue constituents? collagenase, neutral protease, elastase, and acid cathepsins have
been variously described, active individually or together against
collagen, protein polysaccharides, elastin,

arterial cell walls,

and isolated vascular basement membrane,^(review) These en¬
zymes have been identified in neutrophil granules together with
various acid hydrolases present in lysosomes of other cell types

27

with certain enzymes or proteins that have specific anti-bacter¬
ial activity (Lysozyme,"Leukin," and "Phagocytin")

* 4;? and with

a group of "basic cationic proteins" which togetner with bacter: •
p

cida1 actions cause increased vascular permiaoility,

9 /

9 O

9 p -5

*

Although mechanisms have been shown for the mobili¬
zation of these various substances in the intracellular digestion
of phagocytized particles, mechanisms for the release of these
granular substances extra-cellularly have been less clear.

?
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There is strong circumstantial evidence, however, that lysosomal
enzymes and proteins are released from neutrophils and play an
important part in the tissue damage of acute inflammation. Evidnece for this already mentioned includes: 1) experimental models
of acute inflammation in which neutrophils must be present in
tissues for tissue injury to occur, 2) the activity of neutrophil
granular enzymes in degrading various tissue constituents.

Evi¬

dence that neutrophil granular enzymes mediate tissue injury also
includes: 3) the experimental production of tissue damage by di¬
rect infusion of neutrophil granule suspensions or granule ex¬
tracts into the skin of animals,

>

•

'•

4) the inhibition

by certain anti-inflammatory drugs of experimentally induced
diruption of isolated lysosomes _in vitro, or inhibition of
neutrophil degranulation during phagocytosis. <-,»->^»40,4I
It will be remembered that Metchnikoff in his orig¬
inal reports argued against the proposition that "cytases'’
escape from neutrophils during their normal function.

Since

1960, however, several studies with human and non-human neutro¬
phils j^n vitro have shown that a portion of their granular enzymes
are extruded when these cells phagocytize various paricles -bacteria,

immune complexes, yeast and starch granules,33,42-52
Studies to be presented in this report provide direct

evidence that neutrophil granular enzymes not only disappear
from these cells during phagocytosis but also appear in the
surrounding media in which the leukocytes are phagocytizing part¬
icles, Also these studies demonstrate that the immediate fate

8-
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of granular enzymes during phagocytosis depends in part upon
the respective stabilities of these enzymes in soluble phase.
Furthermore, these studies demonstrate that the release of gran¬
ular enzymes from phagocytizing leukocytes may be inhibited
by certain anti-inflammatory drugs (colchicine and cortisol)
but not by another such drug (salicylate).

_Q _

II. THE RELEASE OF LYSOZYME FROM HUMAN LEUKOCYTES
DURING PHAGOCYTOSIS

Experiments with rabbit neutrophils .in. vitro have
demonstrated that various granule-bound enzymes are redistrib¬
uted within the cells as a consequence of phagocytosis of bac¬
teria; these enzymes were reported to be released from the gran¬
ule fraction of the cells into the cytoplasm or soluble fraction
41

of the cells.

In these studies only small amounts of granular

enzyme activities were recovered from the extra-cellular medium
of the phagocytizing cells, and no decrease of net intracellular
enzyme activities was found to occur.

42

Subsequent studies with

human leukocytes jin. vitro were reported to demonstrate a compar¬
able redistribution of granular enzymes intracellularly when these
cells phagocytized immune complexes (Gamma G - Rheumatoid Factor);
similarly these studies did not report significant losses of
enzyme activities from the leukocytes. 4
More recently, however, several studies have been re¬
ported which demonstrate or suggest significant release of gran¬
ule associated enzymes from neutrophils consequent to phagocytosis
of a variety of particles in vitro. Both human^10 *
rabbit"

'"f

*

> 51 and

neutrophils have been used in these experiments;

enzymes shown to be released into the extra-cellular media of
phagocytizing cells include: lysozyme?"*'" ’
acid protease (cathepsin) ,“
aline phosphatase,^

*"

acid phosphatase? *~"

B-glucuronidase,

and peroxidase,14

6>^

* "

alk¬

Release of granular enzymes
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has been reported to occur with phagocytosis of bacteria (E. coli,
Bacillus subtilis"," M.

lysodeikticus, '

and Staphylococci'

1

),

immune complexes (bovine serum albumin-anti BSA,precipitates
/ c

of Staphylococcus cell-wall antigens in specific immune sera
and inert particles (globulin coated latex beads,"
icles,"1

>-

■

and starch granules1^

),

zymozan part¬

.

In the following experiments I have investigated the
intracellular redistribution and the extra-cellular release of lysozyme
from human leukocytes during phagocytosis of Staphylococcus,
let hods
Glassware:
All glassware used in these experiments was made sterile
and pyrogen free by heating st 163°C for 2 hrs.

In addition,

glassware used in the isolation and incubation of leukocytes
(pipettes, centrifuge tubes, and flasks) was siliconized to pre¬
vent sticking of the cells to the glass.
Isolation of Leukocytes from Human Blood:

40

Up to 150 ml of blood was drawn from the antecubital
veins of normal volunteers; the blood was heparinized (10 mg/100 ml),
mixed with 2 vol. of Dextran solution

and allowed to sediment

in 100 ml cylinders at room temperature for 20-30 min. The leuk¬
ocyte rich supernatant was then centrifuged in 50 ml tubes at
1200 rpm (800 g)

in an International Centrifuge, model PR-2, for

15 min. The new supernatant was removed and the cell button re-

3% Dextran of M.W. 100,000-200,000 (Nutritional Biochemical Corps,,
Cleveland, Ohio) in normal saline, autoclaved for 2 hrs and stored
at 4°C.

■
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suspended in modified Krebs-Ringer phosphate buffer at pH 7.4.
The resulting cell suspensions were again centrifuged and the sup¬
ernatants removed. The cell buttons were each gently mixed
over ice with 3 ml sterile distilled water for 20 sec, to lyse
the red cells, and then mixed with 1 ml 3.6% NaCl to restore
isotonicity. The cells were washed once more in buffer, resuspended
in a small volume of buffer, counted with a Coulter particle
counter, and adjusted to the desired concentration. Wright-stained
slides were prepared for differential leukocyte counts of all cell
isolates;

it was found that regularly 60-75% of the leukocytes

were neutrophils.

Heat-killed Bacteria:
Cultures of Staphylococcus albus were stored on blood
agar plates at 4 C and passed to new plates every three weeks.
For the experiments, the bacteria were cultured for 18 hrs in
beef-heart infusion broth, centrifuged, washed once in normal
saline, and then suspended in a small volume of saline. The
concentration of bacteria was estimated from a constructed curve
of transmittance at 600 mu and confirmed by quantitative plating
in agar. The bacteria were killed by autoclaving at 15 lbs pres¬
sure for 20 min. Aliqots of 4-5 ml were frozen and stored at -20°C.

"this buffer was sterilized by autoclaving for 2 hrs the individual
constituent solutions which were: Krebs-Ringer base (100 parts
.9% NaCl, 4 parts 1,15% KC1, 0,6 parts 1.22% CaCl2, 0.2 parts
3,82% MgSO^) and phosphate buffer (14.3 gm N^HPO^ in distilled (cont,)
a strain originally obtained from a finger abscess

. '
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Incubation of Leukocytes:
1.0 ml of leukocyte suspension (containing 2,6-3,4 x 10
leukocytes/ml) were incubated in 25 ml flasks with 1,5 ml buffer,
0,3 ml autologous serum from the blood donor, and 0,2 ml saline
or bacteria suspension, for 1 hr at 37.5°C in a shaking water
bath, 25 ml Erlenmeyer flasks with 2,7 ml buffer and 0,3 ml
serum were also prepared and incubated concurrently.

In each

experiment flasks containing leukocytes with or without bacteria
were incubated in duplicate;

in each experiment phagocytizing

leukocytes and control leukocytes without bacteria were prepared
at the same time from the same blood donor and were incubated
concurrently.

Preparation of Leukocytes for Morphology’14^
Drops of cell suspensions after incubation were
placed on sterile slides, then covered with sterile coverslips.
After incubating the slides for 20 min at 37°C in covered petri
dishes containing a moist filter paper, the coverslips were re¬
moved, quickly air dried, then stained with Wright’s stain.

Preparation of Cell Fractions:
After incubation, leukocyte suspensions were centri¬
fuged in 12 ml tubes at 1200 rpm (International Centrifuge) for
10 min at 4°c, The supernatants represented the "extra-cellular
water, adjusted to pH 7.4 with 16(1) ml of 1 N HC1, and made up
to 1000 ml.') For each experiment 10 mg/100 ml heparin was added
to the final K-R buffer solution which consisted of 105 parts
Krebs-Ringer base and 20 parts Phosphate buffer.

-13-

media fractions." The cell buttons were either resuspended in
0,2 M sucrose up to 3.0 ml, representing the "whole cell frac¬
tions," or they were resuspended for preparation of "nuclear,"
"granular," or "soluble" cell fractions. The preparation of these
latter three cell fractions was done according to a previously
53
reported method. By this method the cell buttons, having been sep¬
arated from the media, were resuspended in 5.5 ml of 0,2 M
sucrose; 0,3 ml heparin (5000 U/ml) was added to the cell suspen¬
sions and gently mixed with a pasteur pipette until marked viscos¬
ity appeared^ indicating cell lysis. The lysate suspensions were
then centrifuged at 1200 rpm (International Centrifuge) for 10
o

f

min at 4 C; the su-spernatants were transferred to high speed
Sorvall tubes and centrifuged at 10,000 rpm (12,000 g, Sorvall
Centrifuge Superspeed SS-3) for 20 min, while the buttons were
resuspended to 3 ml in 0.2 M sucrose and saved as the "granular"
fractions. All fractions were frozen and stored at -20°C not more
than three days until enzyme determinations could be made.
When enzyme activities were measured, the values obtained for the
"soluble" fractions were multiplied by a factor of 2 in order
to adjust for differences in dilution.

Determination of Lysozyme:
The assay for lysozyme activity used in these ex¬
periments is an adaptation of a commonly used turbidometric
54
method,"
3,0 ml aliquots of substrate solution

were warmed to

80 mg of a standard M. lysodeikticus cell wall preparation,
Bacto-Lysozyme Substrate, Difco laboratories, Detroit, Mich., (cont, next pg)
^"buttons from this centrifugation were resuspended to 3 ml in 0.2 M
sucrose and saved as the "nuclear" fractions.
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37°C.

0.5 ml of sample to be measured was then added to an

aliquot of the substrate suspension, mixed, and transferred to
a spectrophotometer cell

which had also been warmed to 37°C.

Lysozyme activity, or lysis of the cell walls in suspension, was
represented by change in optical density at 540 mu over timej
enzyme activity was expressed in terms of ugms. of egg-white
lysozyme”'

and in terms of ugms. of purified human lysozyme isol¬

ated from leukemics* urine,

according to standard curves prepared

at the time of the enzyme assays,^ Before enzyme determinations
were made, all fractions were freeze-thawed 5 times with 0.1 ml
of 1.0% Triton-X 100, a neutral detergent.

Determination of Lactic Dehydrogenase:
Leukocyte LDH determination was measured by an accepted
method for serm LDH determination,

55
^ 0,1 ml of the sample to be

measured was mixed with 2.85 ml of Pyruvate solution (0.05 M phos¬
phate buffer at pH 7.5, 3.1 x 10~^ Pyruvate) and 0.05 ml DPNH
solution (8 x 10

-3

M B-DPNH in Pyruvate solution).

Change in

optical density at 340 mu, which occurred with oxidation of
DPNH, was recorded with a spectrophotometer equipped with a re¬
corder

; temperature of the reaction was controlled at 25°C.

LDH activity was expressed in Uroblewski units.

~

suspended in 50 ml of buffer at pH 6.2, Bacto-Lysozyme Buffer,
Difco. Labs., and homogenized with a teflon pestle for 2 min.
Hitachi Perkin-Elmer Spectrophotometer #139, equipped with a
Sargent Recorder SRL
Bact-Lysozyme, Difco Labs,
Human Lysozyme, courtesy of Dr. Stuart Finch
Rohm and Haas Co,, Phil,,Pa,

t measurements

of lysozyme and LDH in the "media”' fractions were
always adjusted for enzyme activities in the serum which made up a
portion of the incubation media.

-15-

esults
The localization of lysozyme activity in the extra¬
cellular media and in the various cell compartments, when leuk¬
ocytes have been incubated for 1 hr with and without bacteria,
illustrated in Fig.

is

1. Active phagocytosis with most neutrophils

ingesting more than 5 bacteria was demonstrable microscopically
for the leukocyte cultures incubated with bacteria (at a mult¬
iplicity of 10-20 bacteria to I neutrophil). Only neutrophils
and monocytes (the latter cell type representing no more than 5-8%
of the isolated leukocytes) were observed to ingest bacteria.
In Fig,

1 it is evident that the greatest changes in distribution

of lysozyme which occur with phagocytosis are in the "granular”
and in the "medium" fractions,

indicating a release of lysozyme

into the incubation media during phagocytosis. A negligible
increase of lysozyme activity was observed in the "soluble" or
cytoplasmic fraction -- a finding which differs from observations
made with other granular enzymes in rabbit neutrophils,14'1' This
finding, however, agrees with observations of others with acid
and alkaline phosphatase, B-glucuronidase, and peroxidase in
human leukocytes,

1

The decrease in lysozyme activity that occurs in

the

"nuclear" fraction with phagocytosis may be considered to re¬
present for the most part a decrease in the granule bound fraction,
for the "nuclear" fraction was found microscopically to contain
a proportion of whole leukocytes which had not been lysed in
the fractionation procedure, as well as a proportion of adherent

16
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granules j this finding corresponds to the experience of others
in preparing leukocyte fractions.

27 53
*

In these experiments, as the media enzyme activity is
found to increase after phagocytosis, the total cellular enzyme
is found to decrease. Also of note is the fact that the total
enzyme (cellular + media enzyme) recovered from the cultures in
which phagocytosis occurs is less than that recovered from control
t
cultures.
The kinetics of the shift of lysozyme activity from
the cells to the extra-cellular incubation media during phag¬
ocytosis were investigated with varying degrees of phagocytic
challenge (multiplicity of bacteria/ neutrophil) and with vary¬
ing incubation times. The results of these experiments are pre¬
sented in Figs, 2 and 3.

It is evident in Fig, 2 that the extra¬

cellular release of lysozyme increases x^ith the phagocytic chal¬
lenge up to a certain point (about 30 to 1, bacteria to neutrophils)
at which multiplicity the release of enzyme appears to remain
fairly constant; this finding is perhaps best explained by the
supposition either that the leukocytes become saturated with
ingested bacteria at a high multiplicity or that the mechanism
by which enzyme is released from the cells has a limit, When the
leukocytes are incubated at a high multiplicity (Fig, 3),

it is

evident that most of the extra-cellular release of lysozyme occurs
during the first 30 min of incubation, by xvdiich time most of the
phagocytosis is knoxm to have occurred.

27

The data of Fig, 3

+in Fig. 1 total enzyme activity recovered from the M,N,G, and S
fractions of phagocytizing cells is °0% of that recovered from
combined fractions of control cells.

t

or
indicated;

(human Lysozyme)

13.5 - 27.
the results

CHAH-6i\/6E

lvso ivne

to -MifV-

SEM*s are

- 8.2 ugm/ml

(egg-white Lysozyme);

enzyme- 4.1

PtdioD.

represent mean values for 4 experiments.

ugm/ml

Total

INCv/aflri<7i\j

£*t«a - cellular
release
of
WTTH
IrJQREASM'/fr
PnAt»6> UC

18

c_b

V- UJ
X >
U* O

ro

U-4

SOU?

a/'H

a -

3HU
n <iu.vqyoni
j.v
VKtJly
A/ouygnjA/i
wojj
<T3a3A0?3»
3WAZN3
7tAL«X
jo

dNK

iN3:j(3d

2
U experiments;

SEM's are

(human Lysozvme)

UJ
\/% t
or

11.**

- 2U.
indicated.

results represent mean values for

7.2 ugm/ml

■r

(egg-white lysozyme);

enzyme ** 3.5 -

UJ -

ugm/ml

Total

-19-

£

correspond to previously reported findings which related the
appearance of granular enzyme extra-cellularly to time of phag¬
ocytosis,'

'

The values for total leukocyte lysozyme, which

were found to vary with different leukocyte isolations and
with different blood donors, agree with absolute values of lysozyme
activity recovered from leukocytes reported by others (12.0 - 22.0
ugms egg-white lysozyme/ 10

WBC’s isolated from five normal

controls). '
Since it was important to know if the extra-cellular
release of lysozyme, which was observed to occur with phagocytosis,
represents injury to neutrophils, phagocytosis experiemnts were
performed in which both lysozyme and lactic dehydrogenase,

a non¬

granule bound enzyme located in the cytoplasm, were measured
concurrently. The results are presented in Fig. 4. These exper¬
iments demonstrate that, while lysozyme is released from the
leukocytes, coincidental release of IDH does not occur. These
results confirm findings of others who compared the fate of nongranular and granule bound enzymes in a similar experimental
system.

These results also support the conclusion that mobilization

of granular enzymes during phagocytosis is not accompanied by
decreased viability of the leukocytes; studies with similar exper¬
imental systems have demonstrated, by dye exclusion techniques,
no loss of viability of neutrophils as a consequence of phagocytosis.49-51
Discussion
It would be dangerous to assume that the release of
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lysozyme with phagocytosis is a model for the behavior of other
enzymes associated with neutrophil granules.

In fact,

there is

evidence that lysozyme may be differentiated from other granular
enzymes, at least in rabbit neutrophils, according to the extent
to which it is associated with the granular fraction (about 50%,
compared with 60-70% for other enzymes, eg, acid phosphatase and
„ 27
B-glucuronidase),
and according to the specific granules with
57 58
which lysozyme is associated,"
In studies of rabbit neutrophil granules,

investigated by/\gradient centrifugation,

lysozyme

activity was found to be associated with two types of granules -small sized granules where most other granular enzymes are located^
and somewhat larger granules in which alkaline phosphatase was
S7JS6

also found. These studies suggest that human neutrophils, also,
may contain divers granule types. Therefore, one must be cautious
in draxtfing conclusions about neutrophil granular enzymes in gen¬
eral from studies of lysozyme alone.
On the other hand, the results of these experiments
with human leukocytes, demonstrating the shift of lysozyme activity
from the granules to the extra-cellular media, correspond very
closely to previously reported experiments that demonstrate a
shift of B-glucuronidase from the "granular” to the extra-cellular
/ /r

fractions when human leukocytes ohagocytize starch particles,"'’
In another study the peroxidase of human neutrophils was found
to behave similarly with phagocytosis.
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The loss of acid phosphatase activity from human
leukocytes when these cells phagocytize particles has been re¬
ported by several investigators;^’ ^

their results correspond

to the findings of the present experiments and clearly differ
from results of earlier studies with rabbit neutrophils,

in
f ry

which ho loss of granular enzymes were found after phagocytosis.
Even with rabbit neutrophils, however,

“

several more recent stud¬

ies have demonstrated a release of granule associated enzymes
comparable to the results presented here with human leukocytes.^’
A net loss of enzyme activity (incubation media enzyme +
cellular enzyme) noted in these experiments, when leukocytes
were challenged with a high multiplicity of bacteria to be in¬
gested, has not been reposed by other investigators. Despite
trying different methods of releasing the lysozyme activity
from the various fractions (eg,

sonication,

thawing), I was unable to alter this result.

increased freeze¬
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III. THE EFFECTS OF COLCHICINE, CORTISOL, AND SALICYLATE
UPON THE EXTRA-CELLULAR RELEASE OF LYSOZYME FROM LEUKOCYTES

It has been proposed that various anti-inflammatory
drugs work in part by virtue of an effect upon the mobilization
of the granular enzymes contained in neutrophils.'Evidence for
this have been provided by a variety of studies which have demon¬
strated that divers anti-inflammatory drugs protect _in_ vitro
suspensions of lysosomes (derived from rat liver cells) against
spontaneous or induced disruption which would otherwise release
the activity of their bound enzymes.
icoids,

''

.reviews) Glucocort¬

GOich£cjne f 62 ancj aCetyl sal icy lie acid^ have

each been reported as having a "stabilizing” effect upon rat
liver cell lysosomes, although certain investigators have refuted
these findings with cochicine^®*^ and salicylate^ Colchicine
has, however,been shown to inhibit the degranulation of the in¬
tact, phagocytizing neutrophil, and it has been suggested that
this drug inhibits intracellular mechanisms by which the granules
fuse with phagocytic vacuoles containing ingested particles.*1' ’
The proposals that these anti-inflammatory drugs have
a pharmacological action by virtue of an effect upon the re¬
lease of granular enzymes within the phagocytizing leukocyte,
have assumed that these digestive enzymes are also released in
active form, to some extent, outside the cells and thereby be¬
come available for tissue damage at the site of neutrophil infil¬
tration. The experiments with lysozyme presented above, and recent

-25.

studies by others with lysozyme and other granule associated
enzymes, provide direct evidence that granular enzymes do es¬
cape from neutrophils, particularly when these cells phagocytize
large numbers of particles.
The following experiments demonstrate that while
colchicine and cortisol inhibit the release of lysozyme from
phagocytizing leukocytes,salicylate does not have this effect.

Methods
Phagocytosis by Drug Treated Leukocytes:
For each experiment sufficient donor blood was drawn
in order to provide leukocyte isolates (as described) for 16
leukocyte cultures.

In the experiments each culture flask con¬

tained 2,9 - 3,1 x 10^ leukocytes in serum buffer media as des¬
cribed; each flask was preincubated with or without drug for
30 min after which the leukocyte cultures were incubated with
or without heat-killed Staphylococci

(at adjusted concentrations

such that the multiplicity of bacteria to neutrophils was 30 to 1)
for an additional 60 min; each culture contained a final vol¬
ume of 3.0 ml The following experimental alternatives were
prepared and incubated concurrently and in duplicate:
1.
2.
3.
4.
5.

Leukocytes
leukocytes
Leukocytes
Leukocytes
Leukocytes

Colchicine: U.S.P.,

+
+
+
+
+

serum-buffer media
media + bacteria
media with Colchicine
(2.5xlO“3M)
media with Colchicine + bacteria
media with Na Salicylate
(2.2x10”3M)

Sigma Chem, Corp., St, Louis, Mo,

' Na Salicylate: U.S.P., Mallinckrodt Chem,,

St, Louis, Mo.
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6. leukocytes + media with Na Salicylate
+ bacteria
7. leukocytes + media with Cortisol
(5xlO"“'M)
8. leukocytes + media with Cortisol + bacteria
In each experiment the various cultures were incubated
at the same time, with leukocytes prepared from the sane blood
donor (although different donors were used
experiment)

from experiment to

in order that the comparison among drug and control

groups would be the more meaningful by adjusting for variations
in the experimental system, eg, numbers of leukocytes, mult¬
iplicity of bacteria (an effort was made to keep these num¬
bers as constant as possible), and different blood donors.
After incubation, cells were separated from their media,
and the the cellular and media lysozyme activity was measured as
previously described. None of the drugs at the concentrations
used had a demonstrable effect upon the assay for lysozyme.
Several separate experiments were done in which control
cultures were compared with cultures to which acetylsalicylic
**

acid

(10

M) was added, both groups incubated as described

above, with and without bacteria.
Separate experiments were also done in which isolated
human neutrophil granules (prepared as described for the "granular
fraction") suspended in 3.0 ml K-R phosphate buffer, with or without
10"^M acetylsalicylic acid, were incubated at 37.5°C for varying
periods of time (0 min, 60 min, and 180 min). After incubation
'"Cortisols Hydrocortisone Sodium Succunate (Solu-Cortef) , Upjohn,
Kalamazoo, Mich.
‘“Acetylsalicylic Acid: U.S.P, Merck and Co., West Point, Pa.

.

-27-

the granule suspensions were centrifuged at 10,000 rpm for
20 min (Sorvall centrifuge). The supernatants and the pellets,
which were resuspended in an equal volume (up to 3.0 ml)

in 0,2 M

sucrose and were then freeze-thawed x 5, were both measured
for lysozyme activity.

(Note: The concentration of acetylsalicylic

acid (10”^m or IS mg%) used in these separate experiments,
than that used for

rva

lower

salicylate, was necessitated by the rel¬

ative insolubility of ASA.)

Results
There was some variation from experiment to experiment
in the percentage of total enzyme activity lost from the leuk¬
ocytes during phagocytosis (32 - 60%) and in the percentage of
total enzyme activity gained in the extra-cellular media (15 - 33%).
However, within individual experiments,

colchicine and cortisol in¬

hibited the release of lysozyme from the leukocytes into

the

media, whereas salicylate did not have this effect. These exper¬
iments are summarized in Fig.5;

since the drug treated cultures

without bacteria showed no significant differences from the control
cultures without bacteria, these values are not included in Fig.5,
The mean differences between the control and drug treated ex¬
perimental groups are given in Table lj

the differences between

control extra-cellular media and the media from drug treated
cultures, as well as the differences between control cell lysozyme
and drug treated cell lysozyme,

are statistically significant

for the colchicine and cortisol groups.
"by paired t-test
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Slides were prepared for morphology from all leukocyte
cultures after incubation,* all drug treated samples showed active
phagocytosis by neutrophils which had been exposed to bacteria.
Photomicrographs of representative neutrophils containing in¬
gested Staphylococci are presentedin Fig.

6, None of the drugs

appeared to prevent or inhibit phagocytosis at the concentrations
of drugs used.

In Fig.

2 there is further evidence that differ¬

ences in ingestion did not produce the differences observed in
enzyme activity release; for this to be the case, drug treated
cells would have had to have ingested only one half as many
bacteria as control cells -- clearly not the case.
Separate experiments comparing control cells with
cells treated with acetylsalicylic acid (10

-3

or 18 mg%)

ailed

to show an effect by this drug upon the release of lysozyme
during phagocytosis (Fig,

7).

In two experiments this drug

also failed to "stabilize” isolated granules against spontaneous
disruption when granule suspensions were incubated in the
presence of the drug,

(Fig, 8).

Discussion
Although both colchicine and cortisol prevent the
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release of lysozyme from phagocytizing leukocytes, as one would
predict from the demonstrated effects of these drugs in other
systems (inhibition of degranulation or "stabilization" of iso¬
lated lysosomes against disruption),

salicylate was not found fo

have this effect. It may be that the concentration;

of salicylate

used, or the time of pre-incubation of the leukocytes with drug
before they were challenged with bacteria, were inappropriate
for producing an effect in this experimental system. However,
the concentrations of salicylate used,

1-2,2 x 10

-3

M, represent

the upper limit of a pharmacologic plasma level (18 - 35 mg%)
and were larger than concentrations of salicCylate previously
reported to have an effect of "stabilizing" lysosomes of rat
-5
liver cells (concentrations as low as 10” M acetylsalicylic
acid were reported to have this effect).
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In several experiments

in which I attempted to "stabilize" neutrophil granules against
disruption, no effect of salicylate was found. Experiments
presented here,

in sum, refute the proposal that salicylate owes

part of its anti-inflammatory action to an effect upon the mobiliz¬
ation of granular'enzymes in inflammatory leukocytes.
On the other hand these experiments lend further
support for the hypothesis that granular enzymes are mobilized
by neutrophils during phagocytosis and are released in part into
the extra-cellular spaces, particularly with active phagocytosis.
Inhibition of this process by colchicine and cortisol may ac¬
count,

in part, for their anti-inflammatory actions in vivo.
It is important to note that the concentrations of
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colchicine used in these experiments ( and in similar ex¬
periments reported by others) are much, higher than plasma
levels of drug that are apparently achieved _in vivo with
normal therapeutic doses (as much as 1000 times as high by one
report).^"1 Because of this discrepancy between _in vitro and in
vivo drug levels,

it has been suggested that among the numerous

effects of colchicine upon divers stages of the inflammatory
process only those effects which can be demonstrated at concen¬
trations of drug jin vitro comparable to measured plasma levels
may be considered to be important effects pharmacologically.

*
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Inhibition of neutrophil chemotaxis is one effect reported to
occur at such concentrations of drug j_n vitro.
Certainly this is an important consideration. However,
it would be erroneous to assume that the concentrations of
drug to which neutrophils are exposed in these experiments may
be equated entirely or even in part to in vivo plasma levels;
plasma levels by themselves do not indicate intracellular con¬
centrations of drug, nor do they account for time of exposure.
In these experiments drug effects are demonstrated after only
60 - 00 min exposure of neutrophils to drug, whereas the anti¬
inflammatory effects of colchicine

> are observed and

measured over much longer periods of time. Furthermore,

since

colchicine appears to have a series of effects upon neutrophils,
it is to be expected that much lower concentrations may be re"Plasma levels of colchicine after therapeutic doses have been
reported to range between 1 and 3 ugms/100 ml; drug concentration
used in these experiments is lOugm/ml.

-
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quired to show an anti-inflammatory effect _rn vivo than are
required to demonstrate a single effect in an _in vitro ex¬
perimental model,
A similar discussion is appropriate concerning the
concentrations of Cortisol used in these experiments. In studies
which measured plasma cortisol levels achieved in normal volunteers
after oral doses of 200 mg Hydrocortisone Acetate, maximum levels
67
of 125-ugm/ml were found. This compares with a concentration of
18 mg/100 ml of cortisol used in these experiments -- a concentration
about 150 times as high as the jm vivo plasma levels.

Since ther¬

apeutic doses as high as 400 mg of oral hydrocortisone are some¬
times used to suppress inflammatory diseases, and since cortisol
levels achieved in inflammed tissues are known to be higher than
68
in normal tissues, one may argue that the jin vitro levels of
drug used in these experiments are more in the range of 50 times
as high as the reported therapeutic plasma levels of cortisol.in
However, as with colchicine,

it would be erroneous to equate

measured cortisol plasma levels with concentrations of drug found
to have an effect _i_n vitro, for there are obvious differences in
exposure times, cells to drug. Also, as mentioned before, plasma
levels ^in vivo, by themselves, do not indicate cellular concen¬
trations of drug. Furthermore, glucocorticoids, like colchicine,
have been shown to have effects upon several stages of the inflam-

&
matory process, and, as mentioned before,

it would not be unex¬

pected that one effect _in vitro would require a larger concentration
of drug than would the sum of several effects in vivo.

IV. THE EFFECTS OF COLCHICINE, CORTISOL, AND SALICYLATE
UPON THE MOBILIZATION AND RELEASE OF LEUKOCYTE ACID PHOSPHATASE
AND CATHEPSIN

As has been discussed,

it would be dangerous to assume

that all enzymes bound in neutrophil granules behave as does
lysozyme. Therefore, two other granular enzymes -- acid phos¬
phatase and cathepsin (acid protease)

-- were studied in the same

experimental system that has been presented. Both of these
enzymes, as studied by others, have been reported to be released

47,#,49

from neutrophils during phagocytosis.

Methods
The glassware,

solutions, buffer,

isolation and in¬

cubation of leukocytes with and without bacteria, with and with¬
out drugs, as well as the preparation of cellular and extra¬
cellular media fractions for enzyme determinations, were as
previously described.

Measurement of Acid Phosphatase:
An assay for acid phaosphatase which uses a-naphthyl
acid phosphate as a substrate was chosen for several reasons.

69

First, since I wished to measure enzyme activity in an incubation
media made up largely of phosphate buffer,

it was necessary to use

an assay which did not depend upon the measurement of free phos¬
phate split off from a substrate. Second,
to be, as others found it, very sensitive
Third,

this assay proved itself
and reproducible.

in rabbit neutrophils there are at least two acid phospha-

37-
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tases with different substrate specificities: the assay that
uses p-nitrophenyl phosphate as a substrate measures enzyme activ¬
ity which for the most part is not located in the granular frac¬
tions as are other lysosomal enzymes, whereas an assay using B-glycerophosphate as substrate measures enzyme activity located
57 5B
almost exclusively in the small neutrophil granules." ’
The
assay chosen for these experiments, a fluormetric method, has been
observed to have the same substrate specificity as the latter
substrate and to be more sensitive.

7n

0,1. ml of sample to be measured was mixed with 1,0 ml
of 0.1 M acetate buffer at pH 6,1 and with 1.0 ml buffer which
contained a concentration of 5 mM a-naphthyl phosphate sodium"
(or 60 mg/50 ml). Each individual sample was measured in dupli¬
cate, together with a blank, consisting of 0.1 ml sample and
2,0 ml buffer; sample blanks were measured in each case in order
to correct for background fluorescence of the sample itself.
The acetate buffer was made up before the assay procedures and
stored at 4°C; the substrate-buffer solution was

prepared

fresh with each set of assay measurements. The sample-substratebuffer mixtures were incubated at 37°C in a shaking water bath
for 15 min, after which 1,0 ml of 0.5 N NaOH

was added and

the mixture immediately measured for fluorescence in a FOCI
Spectrophotometer Mark I, Ferrand Optical Co/'

Acid phosphatase

Mann Research Labs, N,Y.,N.Y.
'Incident wave length, 340 mu, emitted wave length, 455 mu, optimal
for measuring fluorescence of free a-naphthol which is the
reaction product promoted by enzyme activity.
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activity is expressed as uM/ml free a-naphthol/ 15 min, corrected
for sample blank measurements.

Colchicine and cortisol were not

found to interfere with the assay;

salicylate did, however, cause

an interference which is discussed below.

Measurement of Cathepsin:
The assay for cathepsin used in these studies has been
used commonly in studies of leukocyte granular enzymes.

27

It

.7?
measures proteolysis of denatured hemoglobin at pH 3,/,
0,5 ml
of sample to be measured was added to 0.5 ml distilled water
and 1.0 ml substrate solution.

Each sample was measured in dup¬

licate, Control blanks of 1,0 ml distilled
water and 1.0 ml substrate solution were also prepared.

Samples

with serum-buffer alone or with each of the three drugs in the
experimental concentrations were also measured in order to adjust
for serum enzyme or for drug interference. As with the assay for
acid phosphatase, only salicylate was found to interfere with the
assay (discussed below). All sample-substrate mixtures were in¬
cubated in a water bath at 37°C for 2 hrs,'after which 2,0 ml
of a 5% TCA solution was added to stop the reaction, precipi¬
tating undigested hemoglobin protein. The assay mixtures were
incubated at 37JC for an additional 1 hr and were then centri¬
fuged at 1500 rpm (International centrifuge) for 10 min. The
'2,2% denatured hemoglobin (Hemoglobin Substrate, Mann Research
Labs., N.Y.) in 0,05 M acetate buffer at pH 3.7

r,

’
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supernatants were pipetted into new tubes and stored over night
at 4°C, The supernatants were then measured for free peptides by
the Lowry method

72

2,0 ml "reagent I"
"reagent II"

0,4 ml of supernatant sample was mixed with
and allowed to stand for 10 min, then 0,2 ml

was added and mixed rapidly.

After the mixtures had

been allowed to stand for an additional 30 min, they were read in
a spectrophotometer

at 750 mu for optical density. Results

were translated into ugm protein/ml/ 2 hrs,

from a standard

curve prepared concurrently from protein solutions (bovine albumin)
of known concentration. Results were corrected for assay blank
values.

Effects of the Drugs upon the Enzyme Assays:
None of the drugs affected the total cellular enzyme ac¬
tivities recovered from control leukocytes without bacteria.
Neither colchicine nor cortisol affected the assays for enzyme
activities■in the incubation media.

Salicylate, however,

in¬

terfered with both assays for incubation media enzyme activities.
Salicylate had an intrinsic fluorescence at the wave lengths used
in the acid phosphatase assay, but it was possible to adjust for
this extra fluorescence by subtracting sample blank values (de¬
scribed above).

Similarly, Salicylate interfered with the

cathepsin assay by causing a color reaction by itself in the

100 parts 3% sodium, carbonate in 0,1 N NaOH, 1 part 4% sodium
potassium tartrate, 1 part 2% copper sulphate,
a 1:2 dilution of 2 K Phenol reagent, Fischer Scientific.
Hitachi Perkin-Elmer #139

Lowry reagents -- this interference

was adjusted for by subtracting

salicylate-media blank measurements from sample measurements.

Results
As was demonstrated with lysozyme, phagocytosis of
bacteria by neutrophils is accompanied by a loss of acid phos¬
phatase and cathepsin activity from the cells and an increase in
the activities of these enzymes recovered from the incubation
media (Fig.0), However, the percentages of total enzyme activities
recovered from the extra-cellular media fractions are much
smaller than those observed in measurements of lysozyme, and
the differences of these enzyme activities in the incubation med¬
ia of phagocytizing leukocytes from the enzyme activities in
the media of non-phagocytizing cells xi?ere much too small to
demonstrate significant drug effects. On the other hand differences
among enzyme activities recovered from the cell fractions were
quite sufficient to demonstrate significant drug effects (Fig.
and Table 2), As in experiments with lysozyme,

10

colchicine and

Cortisol consistently inhibited the loss of enzyme activities
from the leukocytes during phagocytosis, whereas salicylate did
not have this effect. The differences between the experimental
groups and the controls were consistently reproduced from ex¬
periment to experiment and are statistically significant.
It was thought possible that smaller percentages of
acid phosphatase and cathepsin were recovered in the extra-cell¬
ular incubation media, than percentages of lysozyme, because of
*>v
by paired t-test
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TABLE 2.

Differences in Cellular Acid Phosphatase and
Cathepsin between Control and Drop Treated Cells
Colchicine

Kean
Differences
i SEK, Cellular
Acid Phosphatase
after Phagocytosis

Kean
Differences
t SEK, Cellular
Cathepsin after
Phagocytosis

13.3%(i2.4)

j><.ooi
n = 3

-1,3%(ll.4)
•p > . 2o , NS
n = 7

7.l%(tl,4)

p K.

Na Salicylate

• ool

n = 3

-1.9%(tl.4)

p >

. lo , US

n = 7

Cortisol
13.07%-2.9)
p < .oor
n = 6

3.3%(+2.0)

p

< -oof

n 53 6

Values expressed in 7 of total enzyme
recovered from non-phagocytizing control cells

differences in the stabilities of these enzymes in the exper¬
imental system. To test this hypothesis, two supplementary
experiments were done.

In the first of these experiments leuk¬

ocyte lysates were incubated for varying periods of time in the
serum-buffer media. Leukocyte suspensions were freeze-thawed in the
presence of 0.1% Triton-X 100 to lyse the cells and release the
granular enzymes into solution; aliquots of lysate in serumbuffer media were then measured immediately for enzyme activity
or were incubated for 30 to 60 min to see if enzyme activities
o
decreased during this time of incubation at 37.5 C. Representative
results from these experiments are indicated in the left-hand
half of Fig.

11.

Acid phosphatase and cathepsin clearly demon¬

strate different stability characteristics than does lysozyme, the
first two enzymes losing 50 - 60% of their activity in 60 min,
while lysozyme loses no more than 8% of its activity during this
time.
Since this experiment compared the behavior of enzymes
contained in a crude cell soup and not of enzymes which had been
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released exra-cellularly by intact leukocytes, according to the
process describ-ed by previous experiments, a second group of
supplementary experiments

was

some increased acid phosphatase

done.

Since it was known that

and cathepsin activity was re¬

covered from the extra-cellular media of phagocytizing leukocytes,
(although this increased activity was small)

large numbers of

leukocytes (3-5xl0^/ml) were incubated with bacteria at a
multiplicity of about 30:1 for 30 min (sufficient time for most
of the enzyme release to occur according to Fig,
tention of causing a large

3)^ with the in¬

release of enzyme during phagocytosis.

After the incubation, the cells were separated from the media by
centrifugation, and aliquots of media were either measured im¬
mediately for enzyme activity or were incubated for varying addit¬
ional periods of time before enzyme activities were measured. Re¬
presentative results are presented in the right-hand half of Fig.
The lysozyme released extra-cellularly from leukocytes loses
little activity with further incubation, whereas the acid phos¬
phatase and cathepsin released from the cells are clearly un¬
stable .

Discussion
As is the case with lysozyme, human leukocytes also lose
acid phosphatase and cathepsin, other granule associated enzymes,
during phagocytosis.

In addition, as was shown with lysozyme,

colchicine and cortisol inhibit the loss of these granular
enzymes from the leukocytes, while salicylate fails to have this

11.
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effect, The inhibition by colchicine of the loss of acid phos¬
phatase from phagocytizing leukocytes confirms previously pub¬
lished data,
was used.

40

in which a different assay for acid phosphatase
Measurements of enzyme activities in the extra-cell¬

ular incubation media did not reproduce the results obtained when
lysozyme was measured; although consistent increases in acid phos¬
phatase and cathepsin activities x^ere observed with phagocytosis,
these increases xrere small and differences x?ere too small to
demonstrate significant drug effects. These txro enzymes, hox<rever,
when incubated free in culture media, proved to be much less stable
than lysozyme, and it seems likely that acid phosphatase and
cathepsin are released from the phagocytizing neutrophils as
is lysozyme, but are not recoverable in convincing amounts be¬
cause of their relative instability during the 60 min period of
incubation.

It is also possible, of course, that some of these

enzymes are degraded within the cells and are not released
extra-cellularly,
The question of enzyme stabilities has not been re¬
ported as important in other studies of this kind.

In the present

studies, however, phagocytosis clearly is accompanied by de¬
creases in total measureable enzyme for all three granular enzymes
investigated.

In one reported study, x/hich compared phagocytosis

by normal human leukocytes x-rith phagocytosis by leukocytes from
patients with Chronic Granulomatous Disease, a decrease in
total acid phosphatase activity i*ecoverable after phagocytosis
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was observed with the normal cells; furthermore,

this decrease

in total enzyme activity was not reproducible with rabbit neutro¬
phils. These investigators, however, did not attempt to explain
their observations by studying enzyme stabilities in their expenmental system.
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V. THE EFFECTS OF COLCHICINE, CORTISOL, AND SALICYATE
UPON THE EXTRA-CELLULAR RELEASE OF LEUKOCYTE "NEUTRAL"
PHOSPHATASE

Because it was apparent that the release of acid phos¬
phatase from phagocytizing leukocytes may be masked by the in¬
stability of this enzyme when freed into the medium,

several

experiemnts were done in which phosphatase substrate was added
to the incubation media. By this maneuver, enzyme released
from the leukocytes could act upon the substrate immediately,
thus "trapping" the enzyme activity before degradation of the
enzyme could occur. For these experiments it was assumed that
the phosphatase-associated reaction occurred at pH 7.4, the pH
of the serum-buffer media;

therefore, the enzyme activity measured

in these experiments is referred to as "neutral" phosphatase.
The effects of Colchicine,

cortisol, and salicylate were compared

under these new experimental- conditions.

Methods
The preparation and incubation of leukocytes with
bacteria was as previously described. Drug-treated leukocyte
cultures were also prepared as described; however, a-naphthyl
phosphate substrate was added to the serum-buffer media such that
the leukocytes were incubated with substrate at a concentration
of 1.75 mg/ml.

It was calculated that this addition ofsubstrate

(a sodium salt) added approximately 28 mOsm to the osmolarity of
the incubation media (fromw308 to 336 mOsm). The incubation
of leukocytes with enzyme substrate is not without precedent;
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a study of the 1950*s used an experimental system whereby leuk¬
ocytes were incubated in the presence of lysozyme substrate in
order to quantify leukocyte damage secondary to various insults
(eg, hypotonicity of the extra-cellu.lar medium, endotoxins)

--

lysis of the substrate was taken as evidence of leukocyte dam17?
age with extrusion of leukocyte enzymes.
After the leukocyte cultures were incubated with or
without bacteria, x^ith or without drug, the cells were removed
by centrifugation. The extra-cellular media fractions were then
made strongly alkaline with the addition of 2,0 ml of 0,5 I
NaOH (necessary for fluorescence of free a-naphthol) and were
immediately measured in a spectrofluorometer (as described above)
Measurements were adjusted, for ’’blank" values, obtained by
measuring the background fluorescence of serum-buffer-substrate
media, with and without the three drugs, which had been incubated
without leukocytes »*■ it will be remembered that

alicylate was

found to cause a sizeable background fluorescence at the wave¬
lengths used for measurements. The fluorescence measurements
obtained from the media of non-phagocytizing cells were com¬
pared with measurements from media containing phagocytizing cells
Slide preparations of leukocytes showed that substrate did not
prevent phagocytosis.

Results and Discussion
Fig,

12 illustrates the increase of fluorescence (or

free a-naphthol)

in the extra-cellular media of phagocytizing
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and non-phagocytizing leukocjrte cultures,

indicating a rise

in

extra-cellular phosphatase activity with ingestion of bacteria
by neutrophils.

Table 3 represents values for the percentages o-f

increased phosphatase activity in the culture media with phag¬
ocytosis for control and drug treated, groups after incubation
periods of

1 hr 7 The increases in extra-cellular phosphatase

activity with phagocytosis

is less for colchicine and cortisol

treated cultures than for controls,
increased enzyme activity
treated cultures.

whereas the percentage of

is slightly more for the salicylate-

The values given in Table 3 represent 6

experiments? variabilities were large and the means are statis¬
tically different at relatively high Mp" values.

However, the

differences among the drug-treated and control groups are
consistent with the results of experiments presented above.

Table 3

__
^
Percentages of Increased Phosphatase Activity
in the Incubation Media with Phagocytosis
Control

Colchicine

Na Salicylate

Cortisol

Mean values of
Percentages
Increased Enzyme
Activity ±SEK

It

is important to note that "neutral" phosphatase activity

(activity at pH 7.4)

recovered from the leukocytes was found to

be located almost entirely in the "granular" fraction,

when

cellular fractions were separated as previously described.
must be added that,

although these results are compatible with

these percentages are comparable to the figure of
Fig,

It

12, which is the percent

73% noted

in

increased phosphatase activity

found in the media of phagocytizing cells compared with phosphatas
activity found in the media of non-phagocytizing cells (at fiomin.')
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findings already presented concerning the actions of the three
drugs studied,

these experiments do not exclusively

cellular enzyme activity.

record extra¬

Phosphatase substrate was found to enter

the leukocytes during phagocytosis
broken down within the cells,
of fluorescence within the

(not unexpectedly)

and to be

as vas evidenced by the appearance

leukocytes

(fluormetric measurements

were made on lysates of cells which had been separated from the
media at various

incubation times).

creased phosphatase activity found

At

least a part of the

in the

in¬

incubation media with

phagocytosis may represent free a-naphthol which had been split
from the substrate within the cells and then leaked out
*
media. Certainly,
and cortisol

into the

these experiments demonstrate that colchicine

inhibit the intracellular mobilization of granule —

associated enzyme activity;
evidence that these drugs

however,

inhibit

these experiments also provide

the extra-cellular release of

granular enzymes during phagocytosis.

As

is apparent

in Fig,

12

there

is phosphatase activity in the

incubation media of non-phagocytizing cells,
concentrations of free a-naphthol during

evidenced by rising

incubation;

part of this

rise represents phosphatase activity of the serum in the media;

part

of this rise represents instability of the a-naphthyl phosphate
substrate; however, some of this rise also represents a reaction
of the substrate with the non-phagocytizing cells,
no explanation.

for which I have
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VI. SUMMARY AND CONCLUSIONS

The role of the Polymorphonuclear Leukocyte (Neutro¬
phil)

in natural protection against infectious disease has been

recognized since the turn of the century. Now, this cell is also
recognized to be of great importance as a mediator of tissue
damage in a variety of acute inflammatory diseases in which the
inflammatory stimuli are harmless without the inflammatory
response which they provoke. The pathologic role of the neutro¬
phil has been delineated best in such experimental models of
human disease as provided by the Arthus Phenomenon and crystal induced acute arthritis,

in which an inflammatory response and

not stimulus is destructive to the animal or human host.
In particular, the various digestive enzymes and spec¬
ific proteins bound in the granules of neutrophils have been
proposed as the active agents contributed by neutrophils in
mediating the tissue damage of acute inflammation.

It is known

that these granular enzymes and proteins are mobilized from their
inactive, bound state during phagocytosis for purposes of destroy¬
ing ingested particles. Also, for some time it has been assumed
that in acute inflammation these lytic agents become available
in the extra-cellular spaces and cause tissue damage, and recently
in various _in vitro experimental systems it has been demonstrated
directly or indirectly‘that granular substances are released
from neutrophils during phagocytosis. Such findings _in vitro
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are compatible with several studies _rn vivo in which increased
plasma or transudate fluid levels of neutrophil granular en¬
zymes have been found coincident with natural or experimental
acute inflammation;

in particular,

lysozyme has been found to

be increased in various body fluids with acute inflammation

74

--

75,76
in fluids from acute arthritic joints,

and in sera of

rabbits injected with large numbers of bacteria or concentrated
so

suspensions of antigen-antibody complexes.
In this report Tn vitro studies have been presented
which Quantitate in detail the loss of lysozyme from human leuk¬
ocytes during phagocytosis together with the appearance of
lysozyme in the extra-cellular incubation media. These studies
have also quantitated the release of lysozyme during phagocytosis
as a function of the time of phagocytosis and as a function of
the phagocytic challenge. Kinetic studies of the release of lys¬
ozyme have shown that the release of the enzyme occurs during
phagocytosis, not at a time when phagocytosis has been completed.
These studies have also indicated that the release of lysozyme
appears to approach a maximum at a certain high level of phagocytic
challenge. Furthermore, these studies indicate that the release
of lysozyme represents a process which is selective for granuleassociated substances and does not represent destruction of
the leukocytes;

lactic dehydrogenase, a non-granular, cytoplasmic

enzyme, was not found to be released during phagocytosis together
with lysozyme.
Other studies also presented demonstrate that two
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anti-inflammatory drugs,

cochicine and dortisol,

inhibit the

phagocytic release of lysozyme, A third anti-inflammatory drug,
salicylate, did not affect the release of lysozyme,

and the fail¬

ure of salicylate to affect this process of granular enzyme release
is

taken as strong evidence that this drug does not act upon

this stage of the inflammatory process as has been previously
suggested.
Studies with acid phosphatase and cathepsin, neutrophil
enzymes which are also bound to the granules of these cells and
are also mobilized during phagocytosis, have demonstrated that
these enzymes are lost from phagocytizing leukocytes as is lys¬
ozyme.

Similarly the cellular loss of these enzymes during phag¬

ocytosis has been shown to be inhibited by colchicine and cortisol
but not by salicylate. Obvious increases in acid phosphatase
and cathepsin activity extra-cellularly were not found as a con¬
sequence of phagocytosis,

in contrast to findings with lysozyme;

however, further studies which demonstrated the relative instability
of these two enzymes in solution offer a likely explanation for
this finding.
Studies, in which leukocytes phagocytized bacteria in
the presence of phosphatase substrate, confirmed the findings
of lysozyme experiments that granular enzymes appear in active
form extra-cellularly during phagocytosis and that this process
is inhibited selectively by colchicine and cortisol but not by
Salicylate.
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Although, as Metchnikoff suggested, disruption of neu¬
trophils may be an important mechanism in the release of lytic
substances from neutrophils in acute inflammation,

it is apparent

that granular enzymes may be released from neutrophils during
active phagocytosis without destruction of these cells. Recently
it has been suggested that the release of granular enzymes from
phagocytizing neutrophils may occur only with the ingestion of
certain kinds of particles (eg,

"indigestible particles").

However, the fact that release of granular enzymes has been
demonstrated or suggested in studies with phagocytosis of a great
variety of particles makes this proposition unlikely. The kinetic
studies presented in this report

relate the release of granular

enzymes directly to the process of phagocytosis and not to an
effect of the ingested particle upon the leukocyte once inside the
cell.

It was once thought that virus particles (or other particles

of small size) were phagocytized by neutrophils but did not cause
mobilization of granular enzymes within these cells; recent quantitative
studies, however, have shown that as soon as viruses (opsonized
by specific antibodies) are cleared from solution by neutrophils
in vitro,

the usual intracellular events of phagocytosis,

in¬

cluding loss of granular enzymes, occur -- when leukocytes are
incubated with viruses but do not undergo these intracellular
changes, they also fail to remove the viruses from solution.

10

This same point has been made in an j_n vivo model:
when sodium urate microcrystals of varying sizes are infused
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into joint spaces,

it appears

that only crystals large enough

to be ingested by neutrophils provoke an inf lamina tory response/
The observation that different neutrophil granular
enzymes are, to varying degrees, unstable

in solution would

appear to be an important one. These instabilities most likely
account for the decreased total enzyme activities found in leuk¬
ocyte cultures in which phagocytosis has occurred. The instabilities
of granular enzymes may reflect an intracellular mobilization of
enzyme inhibitors;

in any case it is not unexpected that the potential

dangers of the toxic granular substances might be naturally limited
by short half-lives of enzymes

once released into solution.

One may postulate that the partial extrusion of granule-associated
lytic enzymes from neutrophils during phagocytosis of invading
micro-organisms is generally of no consequence to the host tissues
because of the short half-lives of these enzymes when free in
solution. The release of granular enzymes becomes of consequence
in producing acute inflammation, however, with circumstances in
which there exists sudden,

localized,

and intense phagocytosis.

VII.
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